How it

100% financing for late-stage approval studies, accelerating your drug development pipeline.

Read more >


Retain absolute ownershipof and control on commercialising the product. What’s yours stays yours.

Read more >

Why Choose

Increased shots on goal supported by global clinical trial expertise and experienced CRO management.

Read more >

Avillion is a drug development company with an innovative business model for the clinical development and approval of late stage pharmaceutical products.

We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to the market. 

Avillion is staffed with a team of expert professionals with extensive experience in the clinical development and regulatory approval of pharmaceutical products on a global basis.

Our offices are in London, United Kingdom, and we are financed by our international investors, AbingworthClarus Ventures and Royalty Pharma.

Contact Us Today